Category: Joint ventures/collaborations
-
Celgene, MorphoSys Partner on Multiple Myeloma Antibody
Celgene Corporation, a biopharmaceutical company in Summit, New Jersey, agreed to license technology and invest in the biotechnology company MorphoSys AG in Munich, Germany for commercializing a monoclonal antibody developed by MorphoSys to treat multiple myeloma and some forms of leukemia. The total potential value of the deal, if all contingencies are met, is €628…
-
AstraZeneca, Roche to Share Preclinical Research Data
The global pharmaceutical companies AstraZeneca and Roche agreed to share early-stage drug research data to speed product development and identify candidates with a greater chance of success. Financial aspects of the collaboration were not disclosed. The two companies will furnish their research data on investigational compounds to a third party, MedChemica, a computational chemistry service…
-
Pharmas, Academics Partner on New Treatments from Old Drugs
Researchers from pharmaceutical companies and academic labs are partnering on finding therapies for eight types of diseases from drugs tested to treat other disorders. The $12.7 million pilot program, led by National Center for Advancing Translational Sciences (NCATS), part of National Institutes of Health, funds nine separate projects combining industry and university scientists for up…
-
3-D Printing, Computer Model Generate Synthetic Bone Matter
Engineers at Massachusetts Institute of Technology in Cambridge and the 3-D printing company Stratasys Ltd. in Billerica, Massachusetts developed a process that translates complex computer-designed models into bone and related organic composite materials with 3-D printing. The team led by MIT engineering professor Markus Buehler published its findings online yesterday in the journal Advanced Functional…
-
Toshiba, Hospitals, USRowing to Study Athlete Heart Deaths
Toshiba America Medical Systems in California is partnering with USRowing, the governing body for competitive rowing in the U.S., and medical centers in Ohio and Mississippi to help determine if sudden cardiac death can be prevented with a heart screening. The Athlete Heart Research Study will initially screen high-school age rowers taking part in USRowing’s…
-
Dana-Farber, Foundation Partner on Expanding Clinical Trials
Dana-Farber Cancer Institute in Boston and Leukemia & Lymphoma Society (LLS) in New York are collaborating on opening new sites for clinical trials to test blood cancer therapies. LLS is investing $1,050,000 over three years in the project. The Blood Cancer Research Partnership aims to make it easier for patients to take part in clinical…
-
First Bioengineered Vein Implanted for U.S. Dialysis Patient
Yesterday, a kidney dialysis patient at Duke University Hospital in Durham, North Carolina was the first in the U.S. to receive a new bioengineered blood vessel developed by a Duke University spin-off company. The patient, a 62 year-old man from Danville, Virginia with kidney failure received in his arm the engineered blood vessel made with…
-
U.K. University to Build Advanced Manufacturing Facility
University of Sheffield in the U.K. says it secured funding for an advanced manufacturing lab to study the needs of the aerospace industry and other high-value manufacturing industries. The £43 million ($US 66.3 million) lab, part of Sheffield’s Advanced Manufacturing Research Centre (AMRC), is supported by Boeing — which has its name on the official…
-
Health Organizations Form Genetics Data Standards Alliance
Some 70 health care organizations worldwide are forming an alliance to develop common standards for collecting and sharing genetic data. The organizations — representing health care providers, government agencies, academic and research institutes, foundations, and advocacy groups — seeks to create a common interoperable framework, with associated regulatory and practical guidelines, for the interchange of…
-
University, Biotech, Life Technologies Partner on Gene Tests
University at Buffalo in New York, the biotechnology company Empire Genomics, and genetics systems developer Life Technologies are establishing facilities at the university to conduct genomic sequencing for research and diagnostics to support personalized medicine. Financial terms of the partnership were not disclosed. Under the deal, Life Technologies is providing equipment from its Ion line…